Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Perjeta Among Biosimilar Targets As Viatris Insists It Can ‘Do A Lot More’
Viatris Has Identified 13 New Biosimilar Targets For Development
Mar 08 2021
•
By
Dean Rudge
Viatris has approximately 150 biosimilar marketing authorizations in over 85 countries • Source: Shutterstock
More from Biosimilars
More from Products